GCM
TARO
Greywolf Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-244,686
| Closed | -$35.1M | – | 9 |
|
|
2016
Q1 | $35.1M | Sell |
244,686
-33,250
| -12% | -$4.76M | 6.05% | 3 |
|
|
2015
Q4 | $43M | Hold |
277,936
| – | – | 7.45% | 3 |
|
|
2015
Q3 | $39.7M | Hold |
277,936
| – | – | 6.51% | 4 |
|
|
2015
Q2 | $39.9M | Hold |
277,936
| – | – | 6.03% | 5 |
|
|
2015
Q1 | $39.2M | Hold |
277,936
| – | – | 10.53% | 5 |
|
|
2014
Q4 | $41.2M | Hold |
277,936
| – | – | 7.3% | 3 |
|
|
2014
Q3 | $42.8M | Hold |
277,936
| – | – | 4.76% | 3 |
|
|
2014
Q2 | $39M | Sell |
277,936
-3,751
| -1% | -$526K | 5.77% | 5 |
|
|
2014
Q1 | $31.3M | Sell |
281,687
-190,448
| -40% | -$21.1M | 6.29% | 3 |
|
|
2013
Q4 | $46.7M | Hold |
472,135
| – | – | 10.17% | 2 |
|
|
2013
Q3 | $35.9M | Buy |
472,135
+1,791
| +0.4% | +$136K | 14.26% | 3 |
|
|
2013
Q2 | $26.3M | Buy |
+470,344
| New | +$26.3M | 10.45% | 5 |
|